BIOMAT Database Logo BIOMAT Database Logo

[Vacuolating cytotoxin (VacA) and cag pathogenicity island (PAI) of Helicobacter pylori]. 2001

A Wada, and T Hirayama
Department of Bacteriology, Institute of Tropical Medicine, Nagasaki University, 1-12-4, Sakamoto, Nagasaki 852-8523.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D016480 Helicobacter pylori A spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. (see Int J Syst Bacteriol 1989 Oct;39(4):297-405). Campylobacter pylori,Campylobacter pylori subsp. pylori,Campylobacter pyloridis,Helicobacter nemestrinae

Related Publications

A Wada, and T Hirayama
Pleiotropic actions of Helicobacter pylori vacuolating cytotoxin, VacA.
January 2010, The Tohoku journal of experimental medicine,
A Wada, and T Hirayama
Conservation of the cag pathogenicity island of Helicobacter pylori: associations with vacuolating cytotoxin allele and IS605 diversity.
December 1999, Gastroenterology,
A Wada, and T Hirayama
[Helicobacter pylori vacuolating cytotoxin (VacA) and its mode of action].
February 2002, Nihon rinsho. Japanese journal of clinical medicine,
A Wada, and T Hirayama
Human gastric glycosphingolipids recognized by Helicobacter pylori vacuolating cytotoxin VacA.
April 2007, Microbes and infection,
A Wada, and T Hirayama
The Helicobacter pylori cag Pathogenicity Island.
January 2012, Methods in molecular biology (Clifton, N.J.),
A Wada, and T Hirayama
Vacuolating cytotoxin A (VacA), a key toxin for Helicobacter pylori pathogenesis.
January 2012, Frontiers in cellular and infection microbiology,
A Wada, and T Hirayama
DNA sequence analysis of South African Helicobacter pylori Vacuolating Cytotoxin Gene (vacA).
January 2011, International journal of molecular sciences,
A Wada, and T Hirayama
Effect of Helicobacter pylori on polymorphonuclear leukocyte migration across polarized T84 epithelial cell monolayers: role of vacuolating toxin VacA and cag pathogenicity island.
September 2000, Infection and immunity,
A Wada, and T Hirayama
Potent neutralization of vacuolating cytotoxin (VacA) of Helicobacter pylori by immunoglobulins against the soluble recombinant VacA.
June 2009, Anticancer research,
A Wada, and T Hirayama
Molecular aspects of Helicobacter pylori cag-pathogenicity island.
April 2011, The FEBS journal,
Copied contents to your clipboard!